Neutra Corp. (OTCBB: NTRR), an emerging nutraceuticals provider, expects to begin clinical trials of its eagerly anticipated new all-natural weight-loss supplement as early as this week when the company’s first batch of Pure Plus arrives from the manufacturer.
NTRR is currently in the midst of recruiting and qualifying suitable volunteers in order to begin testing as soon as the supplements are delivered. The initial test batch as well as each subsequent shipment of Pure Plus is first sent from the manufacturer to a laboratory for a highly specialized Bio-energy infusion that increases the potency of the ingredients, before the supplements’ final delivery to the company.
Beginning clinical trials on the all-natural fat-burner is an exciting, major step forward for the company. Pure Plus will be the first in a product line of superior, all-natural supplements that Neutra Corp. is working to bring to retail shelves as quickly as possible. The breakthrough Bio-energy infusion proven to significantly enhance the supplement’s performance will be the hallmark that sets Pure Plus apart from its competitors.
NTRR expects to announce the results of the trial testing within 30 days of completion.
Neutra Corp. is developing Pure Plus and other new products to compete in the fast-growing nutraceuticals industry alongside Herbalife Ltd. (NYSE: HLF), Nature's Sunshine Prod. (NASDAQ: NATR), Nutraceutical International Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).
For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.
Follow NTRR on Twitter at www.twitter.com/neutracorp.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.